Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19
- PMID: 32356625
- PMCID: PMC7224604
- DOI: 10.1056/NEJMe2012924
Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19
Comment in
-
ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients.Ren Fail. 2021 Dec;43(1):1463-1464. doi: 10.1080/0886022X.2021.1994419. Ren Fail. 2021. PMID: 34704916 Free PMC article. No abstract available.
Comment on
-
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.N Engl J Med. 2020 Jun 18;382(25):2431-2440. doi: 10.1056/NEJMoa2006923. Epub 2020 May 1. N Engl J Med. 2020. PMID: 32356627 Free PMC article.
-
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.N Engl J Med. 2020 Jun 18;382(25):2441-2448. doi: 10.1056/NEJMoa2008975. Epub 2020 May 1. N Engl J Med. 2020. PMID: 32356628 Free PMC article.
References
-
- Esler M, Esler D. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? J Hypertens 2020;38:781-782. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources